The researchers note that the apparent excess risk was concentrated in older adults, men, and people with more advanced diabetes or eye or cardiovascular conditions
Severe allergic reactions very rare, about 0.1% of people in studies
Understanding obesity as a chronic, relapsing illness GLP-1s fold into the treatment conversation for obesity because the cultural discourse around obesity is changing
GLP-1 agonists affect the way your body signals hunger and digests food
Mechanism of Action Incretins hormones like GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) are released throughout the day, increasing at mealtimes
It slows how fast your stomach empties, regulates insulin, lowers blood sugar, and sends a message to your brain that youre done eating